Coherus to Report Third Quarter 2024 Financial Results on November 6, 2024

CHRS 10.30.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-06
Name of Upcoming Event:Conference Call
Full Press ReleaseSEC FilingsOur CHRS Tweets

About Gravity Analytica

Recent News

  • 01.22.2025 - Coherus Presents Final Phase 2 Clinical Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
  • 01.14.2025 - 43rd Annual J.P. Morgan Healthcare Conference
  • 01.08.2025 - Coherus Management to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Recent Filings

  • 01.14.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 01.14.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.14.2025 - PREM14A Preliminary proxy statements relating to merger or acquisition

REDWOOD CITY, Calif.,Oct. 30, 2024(GLOBE NEWSWIRE) --Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that its third quarter 2024 financial results will be released after market close onWednesday, November 6, 2024. Starting at5:00 p.m. ETonNovember 6, 2024, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.

A webcast replay will be available onhttps://investors.coherus.comfollowing the conclusion of the live conference call.

Conference Call Information

When:Wednesday, November 6, 2024, starting at5:00 p.m. Eastern Time

To access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call:https://register.vevent.com/register/BI6dfb4eba6e9a4322a716df863233a53f

Webcast:https://edge.media-server.com/mmc/p/fgk872yp

The press release with the third quarter 2024 financial results and related materials will be available athttps://investors.coherus.combefore the start of the conference call.

A live and archived webcast will be available on the “Investors” section of the Coherus website athttps://investors.coherus.com/events-presentations.

Please dial in 15 minutes early to ensure a timely connection to the call.

Disclosure Information

Coherus uses thehttps://investors.coherus.comwebsite to disclose material non-public information and comply with its disclosure obligations under Regulation FD.

Coherus Contact InformationInvestors:Jodi Sievers, Vice President, Investor Relations and Corporate CommunicationsIR@coherus.com

Primary Logo

Source: Coherus BioSciences, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com